0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Chitosan-based Biomaterial- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Published Date: 2026-06-15
|
Report Code: QYRE-Auto-25B14687
Home | Market Reports
Global Chitosan based Biomaterial Market Research Report 2023
BUY CHAPTERS

Chitosan-based Biomaterial- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Code: QYRE-Auto-25B14687
Report
2026-06-15
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Chitosan-based Biomaterial- Market

The global market for Chitosan-based Biomaterial was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Chitosan-based Biomaterial cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Chitosan is a naturally occurring biopolymer that is derived from chitin, which is found in the exoskeletons of crustaceans such as shrimp and crabs, as well as in the cell walls of certain fungi. Chitosan is a versatile biomaterial that has a range of applications due to its unique properties, including biocompatibility, biodegradability, and antimicrobial activity.
The North American market for Chitosan-based Biomaterial was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Chitosan-based Biomaterial was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Chitosan-based Biomaterial was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Chitosan-based Biomaterial market include Heppe Medical Chitosan GmbH, KitoZyme S.A., Primex EHF, Tosoh Corporation, Golden-Shell Pharmaceutical Co., Ltd., Advanced Biopolymers AS, Primex Technologies Inc, Bioiberica S.A.U., Agratech International, Inc., NanoBioMagnetics S.L., etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Chitosan-based Biomaterial, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Chitosan-based Biomaterial market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Chitosan-based Biomaterial.
Market Segmentation

Scope of Chitosan-based Biomaterial- Market Report

Report Metric Details
Report Name Chitosan-based Biomaterial- Market
Segment by Type
  • Chitosan Hydrogels
  • Chitosan Films and Coatings
  • Chitosan Nanoparticles
  • Chitosan Sponges
  • Chitosan Fibers and Threads
  • Chitosan Beads
  • Chitosan Membranes
  • Others
Segment by Application
  • Biomedical
  • Food
  • Agriculture
  • Textile
  • Environmental
  • Cosmetic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Heppe Medical Chitosan GmbH, KitoZyme S.A., Primex EHF, Tosoh Corporation, Golden-Shell Pharmaceutical Co., Ltd., Advanced Biopolymers AS, Primex Technologies Inc, Bioiberica S.A.U., Agratech International, Inc., NanoBioMagnetics S.L.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
  • Chapter 2: Provides a detailed analysis of the Chitosan-based Biomaterial manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
  • Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Presents Chitosan-based Biomaterial sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
  • Chapter 6: Presents Chitosan-based Biomaterial sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
  • Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
  • Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Chitosan-based Biomaterial- Market report?

Ans: The main players in the Chitosan-based Biomaterial- Market are Heppe Medical Chitosan GmbH, KitoZyme S.A., Primex EHF, Tosoh Corporation, Golden-Shell Pharmaceutical Co., Ltd., Advanced Biopolymers AS, Primex Technologies Inc, Bioiberica S.A.U., Agratech International, Inc., NanoBioMagnetics S.L.

What are the Application segmentation covered in the Chitosan-based Biomaterial- Market report?

Ans: The Applications covered in the Chitosan-based Biomaterial- Market report are Biomedical, Food, Agriculture, Textile, Environmental, Cosmetic, Others

What are the Type segmentation covered in the Chitosan-based Biomaterial- Market report?

Ans: The Types covered in the Chitosan-based Biomaterial- Market report are Chitosan Hydrogels, Chitosan Films and Coatings, Chitosan Nanoparticles, Chitosan Sponges, Chitosan Fibers and Threads, Chitosan Beads, Chitosan Membranes, Others

1 Market Overview
1.1 Chitosan-based Biomaterial Product Introduction
1.2 Global Chitosan-based Biomaterial Market Size Forecast
1.2.1 Global Chitosan-based Biomaterial Sales Value (2021–2032)
1.2.2 Global Chitosan-based Biomaterial Sales Volume (2021–2032)
1.2.3 Global Chitosan-based Biomaterial Sales Price (2021–2032)
1.3 Chitosan-based Biomaterial Market Trends & Drivers
1.3.1 Chitosan-based Biomaterial Industry Trends
1.3.2 Chitosan-based Biomaterial Market Drivers & Opportunities
1.3.3 Chitosan-based Biomaterial Market Challenges
1.3.4 Chitosan-based Biomaterial Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Chitosan-based Biomaterial Players Revenue Ranking (2025)
2.2 Global Chitosan-based Biomaterial Revenue by Company (2021–2026)
2.3 Global Chitosan-based Biomaterial Sales Volume Ranking of Players (2025)
2.4 Global Chitosan-based Biomaterial Sales Volume by Company (2021–2026)
2.5 Global Chitosan-based Biomaterial Average Price by Company (2021–2026)
2.6 Key Manufacturers Chitosan-based Biomaterial Manufacturing Base and Headquarters
2.7 Key Manufacturers Chitosan-based Biomaterial Product Offerings
2.8 Key Manufacturers Start of Mass Production of Chitosan-based Biomaterial
2.9 Chitosan-based Biomaterial Market Competitive Analysis
2.9.1 Chitosan-based Biomaterial Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Chitosan-based Biomaterial Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Chitosan-based Biomaterial revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Chitosan-based Biomaterial Market Classification
3.1 Introduction by Type
3.1.1 Chitosan Hydrogels
3.1.2 Chitosan Films and Coatings
3.1.3 Chitosan Nanoparticles
3.1.4 Chitosan Sponges
3.1.5 Chitosan Fibers and Threads
3.1.6 Chitosan Beads
3.1.7 Chitosan Membranes
3.1.8 Others
3.1.9 Global Chitosan-based Biomaterial Sales Value by Type
3.1.9.1 Global Chitosan-based Biomaterial Sales Value by Type (2021 vs 2025 vs 2032)
3.1.9.2 Global Chitosan-based Biomaterial Sales Value, by Type (2021–2032)
3.1.9.3 Global Chitosan-based Biomaterial Sales Value, by Type (%), 2021–2032
3.1.10 Global Chitosan-based Biomaterial Sales Volume by Type
3.1.10.1 Global Chitosan-based Biomaterial Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.10.2 Global Chitosan-based Biomaterial Sales Volume, by Type (2021–2032)
3.1.10.3 Global Chitosan-based Biomaterial Sales Volume, by Type (%), 2021–2032
3.1.11 Global Chitosan-based Biomaterial Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biomedical
4.1.2 Food
4.1.3 Agriculture
4.1.4 Textile
4.1.5 Environmental
4.1.6 Cosmetic
4.1.7 Others
4.2 Global Chitosan-based Biomaterial Sales Value by Application
4.2.1 Global Chitosan-based Biomaterial Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Chitosan-based Biomaterial Sales Value, by Application (2021–2032)
4.2.3 Global Chitosan-based Biomaterial Sales Value, by Application (%), 2021–2032
4.3 Global Chitosan-based Biomaterial Sales Volume by Application
4.3.1 Global Chitosan-based Biomaterial Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Chitosan-based Biomaterial Sales Volume, by Application (2021–2032)
4.3.3 Global Chitosan-based Biomaterial Sales Volume, by Application (%), 2021–2032
4.4 Global Chitosan-based Biomaterial Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Chitosan-based Biomaterial Sales Value by Region
5.1.1 Global Chitosan-based Biomaterial Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Chitosan-based Biomaterial Sales Value by Region (2021–2026)
5.1.3 Global Chitosan-based Biomaterial Sales Value by Region (2027–2032)
5.1.4 Global Chitosan-based Biomaterial Sales Value by Region (%), 2021–2032
5.2 Global Chitosan-based Biomaterial Sales Volume by Region
5.2.1 Global Chitosan-based Biomaterial Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Chitosan-based Biomaterial Sales Volume by Region (2021–2026)
5.2.3 Global Chitosan-based Biomaterial Sales Volume by Region (2027–2032)
5.2.4 Global Chitosan-based Biomaterial Sales Volume by Region (%), 2021–2032
5.3 Global Chitosan-based Biomaterial Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Chitosan-based Biomaterial Sales Value, 2021–2032
5.4.2 North America Chitosan-based Biomaterial Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Chitosan-based Biomaterial Sales Value, 2021–2032
5.5.2 Europe Chitosan-based Biomaterial Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Chitosan-based Biomaterial Sales Value, 2021–2032
5.6.2 Asia Pacific Chitosan-based Biomaterial Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Chitosan-based Biomaterial Sales Value, 2021–2032
5.7.2 South America Chitosan-based Biomaterial Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Chitosan-based Biomaterial Sales Value, 2021–2032
5.8.2 Middle East & Africa Chitosan-based Biomaterial Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Chitosan-based Biomaterial Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Chitosan-based Biomaterial Sales Value and Sales Volume
6.2.1 Key Countries/Regions Chitosan-based Biomaterial Sales Value, 2021–2032
6.2.2 Key Countries/Regions Chitosan-based Biomaterial Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Chitosan-based Biomaterial Sales Value, 2021–2032
6.3.2 United States Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Chitosan-based Biomaterial Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Chitosan-based Biomaterial Sales Value, 2021–2032
6.4.2 Europe Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Chitosan-based Biomaterial Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Chitosan-based Biomaterial Sales Value, 2021–2032
6.5.2 China Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
6.5.3 China Chitosan-based Biomaterial Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Chitosan-based Biomaterial Sales Value, 2021–2032
6.6.2 Japan Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Chitosan-based Biomaterial Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Chitosan-based Biomaterial Sales Value, 2021–2032
6.7.2 South Korea Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Chitosan-based Biomaterial Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Chitosan-based Biomaterial Sales Value, 2021–2032
6.8.2 Southeast Asia Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Chitosan-based Biomaterial Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Chitosan-based Biomaterial Sales Value, 2021–2032
6.9.2 India Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
6.9.3 India Chitosan-based Biomaterial Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Heppe Medical Chitosan GmbH
7.1.1 Heppe Medical Chitosan GmbH Company Information
7.1.2 Heppe Medical Chitosan GmbH Introduction and Business Overview
7.1.3 Heppe Medical Chitosan GmbH Chitosan-based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Heppe Medical Chitosan GmbH Chitosan-based Biomaterial Product Offerings
7.1.5 Heppe Medical Chitosan GmbH Recent Developments
7.2 KitoZyme S.A.
7.2.1 KitoZyme S.A. Company Information
7.2.2 KitoZyme S.A. Introduction and Business Overview
7.2.3 KitoZyme S.A. Chitosan-based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 KitoZyme S.A. Chitosan-based Biomaterial Product Offerings
7.2.5 KitoZyme S.A. Recent Developments
7.3 Primex EHF
7.3.1 Primex EHF Company Information
7.3.2 Primex EHF Introduction and Business Overview
7.3.3 Primex EHF Chitosan-based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Primex EHF Chitosan-based Biomaterial Product Offerings
7.3.5 Primex EHF Recent Developments
7.4 Tosoh Corporation
7.4.1 Tosoh Corporation Company Information
7.4.2 Tosoh Corporation Introduction and Business Overview
7.4.3 Tosoh Corporation Chitosan-based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Tosoh Corporation Chitosan-based Biomaterial Product Offerings
7.4.5 Tosoh Corporation Recent Developments
7.5 Golden-Shell Pharmaceutical Co., Ltd.
7.5.1 Golden-Shell Pharmaceutical Co., Ltd. Company Information
7.5.2 Golden-Shell Pharmaceutical Co., Ltd. Introduction and Business Overview
7.5.3 Golden-Shell Pharmaceutical Co., Ltd. Chitosan-based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Golden-Shell Pharmaceutical Co., Ltd. Chitosan-based Biomaterial Product Offerings
7.5.5 Golden-Shell Pharmaceutical Co., Ltd. Recent Developments
7.6 Advanced Biopolymers AS
7.6.1 Advanced Biopolymers AS Company Information
7.6.2 Advanced Biopolymers AS Introduction and Business Overview
7.6.3 Advanced Biopolymers AS Chitosan-based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Advanced Biopolymers AS Chitosan-based Biomaterial Product Offerings
7.6.5 Advanced Biopolymers AS Recent Developments
7.7 Primex Technologies Inc
7.7.1 Primex Technologies Inc Company Information
7.7.2 Primex Technologies Inc Introduction and Business Overview
7.7.3 Primex Technologies Inc Chitosan-based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Primex Technologies Inc Chitosan-based Biomaterial Product Offerings
7.7.5 Primex Technologies Inc Recent Developments
7.8 Bioiberica S.A.U.
7.8.1 Bioiberica S.A.U. Company Information
7.8.2 Bioiberica S.A.U. Introduction and Business Overview
7.8.3 Bioiberica S.A.U. Chitosan-based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Bioiberica S.A.U. Chitosan-based Biomaterial Product Offerings
7.8.5 Bioiberica S.A.U. Recent Developments
7.9 Agratech International, Inc.
7.9.1 Agratech International, Inc. Company Information
7.9.2 Agratech International, Inc. Introduction and Business Overview
7.9.3 Agratech International, Inc. Chitosan-based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Agratech International, Inc. Chitosan-based Biomaterial Product Offerings
7.9.5 Agratech International, Inc. Recent Developments
7.10 NanoBioMagnetics S.L.
7.10.1 NanoBioMagnetics S.L. Company Information
7.10.2 NanoBioMagnetics S.L. Introduction and Business Overview
7.10.3 NanoBioMagnetics S.L. Chitosan-based Biomaterial Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 NanoBioMagnetics S.L. Chitosan-based Biomaterial Product Offerings
7.10.5 NanoBioMagnetics S.L. Recent Developments
8 Industry Chain Analysis
8.1 Chitosan-based Biomaterial Industrial Chain
8.2 Chitosan-based Biomaterial Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Chitosan-based Biomaterial Sales Model
8.5.2 Sales Channels
8.5.3 Chitosan-based Biomaterial Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Chitosan-based Biomaterial Market Trends
 Table 2. Chitosan-based Biomaterial Market Drivers & Opportunities
 Table 3. Chitosan-based Biomaterial Market Challenges
 Table 4. Chitosan-based Biomaterial Market Restraints
 Table 5. Global Chitosan-based Biomaterial Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Chitosan-based Biomaterial Revenue Market Share by Company (2021–2026)
 Table 7. Global Chitosan-based Biomaterial Sales Volume by Company (Tons), 2021–2026
 Table 8. Global Chitosan-based Biomaterial Sales Volume Market Share by Company (2021–2026)
 Table 9. Global Market Chitosan-based Biomaterial Price by Company (US$/Ton), 2021–2026
 Table 10. Key Manufacturers Chitosan-based Biomaterial Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Chitosan-based Biomaterial Product Type
 Table 12. Key Manufacturers Start of Mass Production of Chitosan-based Biomaterial
 Table 13. Global Chitosan-based Biomaterial Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Chitosan-based Biomaterial revenue, 2025
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Chitosan-based Biomaterial Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Chitosan-based Biomaterial Sales Value by Type (US$ Million), 2021–2026
 Table 18. Global Chitosan-based Biomaterial Sales Value by Type (US$ Million), 2027–2032
 Table 19. Global Chitosan-based Biomaterial Sales Market Share in Value by Type (2021–2026)
 Table 20. Global Chitosan-based Biomaterial Sales Market Share in Value by Type (2027–2032)
 Table 21. Global Chitosan-based Biomaterial Sales Volume by Type: 2021 vs 2025 vs 2032 (Tons)
 Table 22. Global Chitosan-based Biomaterial Sales Volume by Type (Tons), 2021–2026
 Table 23. Global Chitosan-based Biomaterial Sales Volume by Type (Tons), 2027–2032
 Table 24. Global Chitosan-based Biomaterial Sales Market Share in Volume by Type (2021–2026)
 Table 25. Global Chitosan-based Biomaterial Sales Market Share in Volume by Type (2027–2032)
 Table 26. Global Chitosan-based Biomaterial Price by Type (US$/Ton), 2021–2026
 Table 27. Global Chitosan-based Biomaterial Price by Type (US$/Ton), 2027–2032
 Table 28. Global Chitosan-based Biomaterial Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 29. Global Chitosan-based Biomaterial Sales Value by Application (US$ Million), 2021–2026
 Table 30. Global Chitosan-based Biomaterial Sales Value by Application (US$ Million), 2027–2032
 Table 31. Global Chitosan-based Biomaterial Sales Market Share in Value by Application (2021–2026)
 Table 32. Global Chitosan-based Biomaterial Sales Market Share in Value by Application (2027–2032)
 Table 33. Global Chitosan-based Biomaterial Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons)
 Table 34. Global Chitosan-based Biomaterial Sales Volume by Application (Tons), 2021–2026
 Table 35. Global Chitosan-based Biomaterial Sales Volume by Application (Tons), 2027–2032
 Table 36. Global Chitosan-based Biomaterial Sales Market Share in Volume by Application (2021–2026)
 Table 37. Global Chitosan-based Biomaterial Sales Market Share in Volume by Application (2027–2032)
 Table 38. Global Chitosan-based Biomaterial Price by Application (US$/Ton), 2021–2026
 Table 39. Global Chitosan-based Biomaterial Price by Application (US$/Ton), 2027–2032
 Table 40. Global Chitosan-based Biomaterial Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 41. Global Chitosan-based Biomaterial Sales Value by Region (US$ Million), 2021–2026
 Table 42. Global Chitosan-based Biomaterial Sales Value by Region (US$ Million), 2027–2032
 Table 43. Global Chitosan-based Biomaterial Sales Value by Region (%), 2021–2026
 Table 44. Global Chitosan-based Biomaterial Sales Value by Region (%), 2027–2032
 Table 45. Global Chitosan-based Biomaterial Sales Volume by Region (Tons): 2021 vs 2025 vs 2032
 Table 46. Global Chitosan-based Biomaterial Sales Volume by Region (Tons), 2021–2026
 Table 47. Global Chitosan-based Biomaterial Sales Volume by Region (Tons), 2027–2032
 Table 48. Global Chitosan-based Biomaterial Sales Volume by Region (%), 2021–2026
 Table 49. Global Chitosan-based Biomaterial Sales Volume by Region (%), 2027–2032
 Table 50. Global Chitosan-based Biomaterial Average Price by Region (US$/Ton), 2021–2026
 Table 51. Global Chitosan-based Biomaterial Average Price by Region (US$/Ton), 2027–2032
 Table 52. Key Countries/Regions Chitosan-based Biomaterial Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Key Countries/Regions Chitosan-based Biomaterial Sales Value, (US$ Million), 2021–2026
 Table 54. Key Countries/Regions Chitosan-based Biomaterial Sales Value, (US$ Million), 2027–2032
 Table 55. Key Countries/Regions Chitosan-based Biomaterial Sales Volume, (Tons), 2021–2026
 Table 56. Key Countries/Regions Chitosan-based Biomaterial Sales Volume, (Tons), 2027–2032
 Table 57. Heppe Medical Chitosan GmbH Company Information
 Table 58. Heppe Medical Chitosan GmbH Introduction and Business Overview
 Table 59. Heppe Medical Chitosan GmbH Chitosan-based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 60. Heppe Medical Chitosan GmbH Chitosan-based Biomaterial Product Offerings
 Table 61. Heppe Medical Chitosan GmbH Recent Developments
 Table 62. KitoZyme S.A. Company Information
 Table 63. KitoZyme S.A. Introduction and Business Overview
 Table 64. KitoZyme S.A. Chitosan-based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 65. KitoZyme S.A. Chitosan-based Biomaterial Product Offerings
 Table 66. KitoZyme S.A. Recent Developments
 Table 67. Primex EHF Company Information
 Table 68. Primex EHF Introduction and Business Overview
 Table 69. Primex EHF Chitosan-based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 70. Primex EHF Chitosan-based Biomaterial Product Offerings
 Table 71. Primex EHF Recent Developments
 Table 72. Tosoh Corporation Company Information
 Table 73. Tosoh Corporation Introduction and Business Overview
 Table 74. Tosoh Corporation Chitosan-based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 75. Tosoh Corporation Chitosan-based Biomaterial Product Offerings
 Table 76. Tosoh Corporation Recent Developments
 Table 77. Golden-Shell Pharmaceutical Co., Ltd. Company Information
 Table 78. Golden-Shell Pharmaceutical Co., Ltd. Introduction and Business Overview
 Table 79. Golden-Shell Pharmaceutical Co., Ltd. Chitosan-based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 80. Golden-Shell Pharmaceutical Co., Ltd. Chitosan-based Biomaterial Product Offerings
 Table 81. Golden-Shell Pharmaceutical Co., Ltd. Recent Developments
 Table 82. Advanced Biopolymers AS Company Information
 Table 83. Advanced Biopolymers AS Introduction and Business Overview
 Table 84. Advanced Biopolymers AS Chitosan-based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 85. Advanced Biopolymers AS Chitosan-based Biomaterial Product Offerings
 Table 86. Advanced Biopolymers AS Recent Developments
 Table 87. Primex Technologies Inc Company Information
 Table 88. Primex Technologies Inc Introduction and Business Overview
 Table 89. Primex Technologies Inc Chitosan-based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 90. Primex Technologies Inc Chitosan-based Biomaterial Product Offerings
 Table 91. Primex Technologies Inc Recent Developments
 Table 92. Bioiberica S.A.U. Company Information
 Table 93. Bioiberica S.A.U. Introduction and Business Overview
 Table 94. Bioiberica S.A.U. Chitosan-based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 95. Bioiberica S.A.U. Chitosan-based Biomaterial Product Offerings
 Table 96. Bioiberica S.A.U. Recent Developments
 Table 97. Agratech International, Inc. Company Information
 Table 98. Agratech International, Inc. Introduction and Business Overview
 Table 99. Agratech International, Inc. Chitosan-based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 100. Agratech International, Inc. Chitosan-based Biomaterial Product Offerings
 Table 101. Agratech International, Inc. Recent Developments
 Table 102. NanoBioMagnetics S.L. Company Information
 Table 103. NanoBioMagnetics S.L. Introduction and Business Overview
 Table 104. NanoBioMagnetics S.L. Chitosan-based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 105. NanoBioMagnetics S.L. Chitosan-based Biomaterial Product Offerings
 Table 106. NanoBioMagnetics S.L. Recent Developments
 Table 107. Key Raw Materials Lists
 Table 108. Key Suppliers of Raw Materials Lists
 Table 109. Chitosan-based Biomaterial Downstream Customers
 Table 110. Chitosan-based Biomaterial Distributors List
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources


List of Figures
 Figure 1. Chitosan-based Biomaterial Product Picture
 Figure 2. Global Chitosan-based Biomaterial Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 4. Global Chitosan-based Biomaterial Sales Volume (Tons), 2021–2032
 Figure 5. Global Chitosan-based Biomaterial Sales Price (US$/Ton), 2021–2032
 Figure 6. Chitosan-based Biomaterial Report Years Considered
 Figure 7. Global Chitosan-based Biomaterial Players Revenue Ranking (US$ Million), 2025
 Figure 8. Global Chitosan-based Biomaterial Sales Volume Ranking of Players (Tons), 2025
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Chitosan-based Biomaterial Revenue in 2025
 Figure 10. Chitosan-based Biomaterial Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 11. Chitosan Hydrogels Picture
 Figure 12. Chitosan Films and Coatings Picture
 Figure 13. Chitosan Nanoparticles Picture
 Figure 14. Chitosan Sponges Picture
 Figure 15. Chitosan Fibers and Threads Picture
 Figure 16. Chitosan Beads Picture
 Figure 17. Chitosan Membranes Picture
 Figure 18. Others Picture
 Figure 19. Global Chitosan-based Biomaterial Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 20. Global Chitosan-based Biomaterial Sales Value Market Share by Type, 2025 & 2032
 Figure 21. Global Chitosan-based Biomaterial Sales Volume by Type (Tons), 2021 vs 2025 vs 2032
 Figure 22. Global Chitosan-based Biomaterial Sales Volume Market Share by Type, 2025 & 2032
 Figure 23. Global Chitosan-based Biomaterial Price by Type (US$/Ton), 2021–2032
 Figure 24. Product Picture of Biomedical
 Figure 25. Product Picture of Food
 Figure 26. Product Picture of Agriculture
 Figure 27. Product Picture of Textile
 Figure 28. Product Picture of Environmental
 Figure 29. Product Picture of Cosmetic
 Figure 30. Product Picture of Others
 Figure 31. Global Chitosan-based Biomaterial Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 32. Global Chitosan-based Biomaterial Sales Value Market Share by Application, 2025 & 2032
 Figure 33. Global Chitosan-based Biomaterial Sales Volume by Application (Tons), 2021 vs 2025 vs 2032
 Figure 34. Global Chitosan-based Biomaterial Sales Volume Market Share by Application, 2025 & 2032
 Figure 35. Global Chitosan-based Biomaterial Price by Application (US$/Ton), 2021–2032
 Figure 36. North America Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 37. North America Chitosan-based Biomaterial Sales Value by Country (%), 2025 vs 2032
 Figure 38. Europe Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 39. Europe Chitosan-based Biomaterial Sales Value by Country (%), 2025 vs 2032
 Figure 40. Asia Pacific Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 41. Asia Pacific Chitosan-based Biomaterial Sales Value by Region (%), 2025 vs 2032
 Figure 42. South America Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 43. South America Chitosan-based Biomaterial Sales Value by Country (%), 2025 vs 2032
 Figure 44. Middle East & Africa Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Chitosan-based Biomaterial Sales Value by Country (%), 2025 vs 2032
 Figure 46. Key Countries/Regions Chitosan-based Biomaterial Sales Value (%), 2021–2032
 Figure 47. Key Countries/Regions Chitosan-based Biomaterial Sales Volume (%), 2021–2032
 Figure 48. United States Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 49. United States Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 50. United States Chitosan-based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 51. Europe Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 52. Europe Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 53. Europe Chitosan-based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 54. China Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 55. China Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 56. China Chitosan-based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 57. Japan Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 58. Japan Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 59. Japan Chitosan-based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 60. South Korea Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 61. South Korea Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 62. South Korea Chitosan-based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 63. Southeast Asia Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 64. Southeast Asia Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 65. Southeast Asia Chitosan-based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 66. India Chitosan-based Biomaterial Sales Value (US$ Million), 2021–2032
 Figure 67. India Chitosan-based Biomaterial Sales Value by Type (%), 2025 vs 2032
 Figure 68. India Chitosan-based Biomaterial Sales Value by Application (%), 2025 vs 2032
 Figure 69. Chitosan-based Biomaterial Industrial Chain
 Figure 70. Chitosan-based Biomaterial Manufacturing Cost Structure
 Figure 71. Channels of Distribution (Direct Sales, and Distribution)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$3950

Single User License
Electronic

$5925

Multi User License
Electronic

$7900

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture